← FDA Drug Approvals (Drugs@FDA)

MESALAMINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2020-01-02

Drug application

FDA Application #

ANDA210509

Application type

Abbreviated New Drug Application (Generic)

Brand name

MESALAMINE

Generic name

Mesalamine

Active ingredients

MESALAMINE

Dosage form

SUPPOSITORY

Route

RECTAL

Marketing status

Discontinued

Sponsor

AMNEAL

First approval

2020-01-02

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown